Thrombolysis utilisation in acute myocardial infarction in Bahrain.

Simple item page
dc.contributor.authorChawla, A Ken_US
dc.contributor.authorNambiar, C Aen_US
dc.contributor.authorMurad, A Aen_US
dc.date.accessioned1996-03-01en_US
dc.date.accessioned2009-05-27T04:17:48Z
dc.date.available1996-03-01en_US
dc.date.available2009-05-27T04:17:48Z
dc.date.issued1996-03-01en_US
dc.description.abstractWe retrospectively studied 114 consecutive patients of acute myocardial infarction diagnosed in the Accident and Emergency department of our hospital, to determine the percentage of eligible patients who actually received thrombolytic therapy, the number of those excluded from receiving such therapy and the various exclusion criteria. We found that 66 patients (57.9%) received thrombolysis with either streptokinase or tissue plasminogen activator (tPA). The remaining 48 (42.1%) were excluded because of delayed presentation to hospital after the onset of symptoms (23.7%), old age or other contraindications. Although the percentage of thrombolysis utilisation in acute myocardial infarction in our centre is much higher as compared to others in the world, we find that there is a scope for improving these figures by reducing the number of patients excluded because of late presentation through health education and improved utilisation of ambulance services.en_US
dc.description.affiliationSalmaniya Medical Centre, Bahrain.en_US
dc.identifier.citationChawla AK, Nambiar CA, Murad AA. Thrombolysis utilisation in acute myocardial infarction in Bahrain. Indian Heart Journal. 1996 Mar-Apr; 48(2): 155-8en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/2953
dc.language.isoengen_US
dc.source.urihttps://indianheartjournal.comen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshBahrainen_US
dc.subject.meshFemaleen_US
dc.subject.meshFibrinolytic Agents --therapeutic useen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshMyocardial Infarction --drug therapyen_US
dc.subject.meshPlasminogen Activators --therapeutic useen_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshStreptokinase --therapeutic useen_US
dc.subject.meshThrombolytic Therapy --utilizationen_US
dc.subject.meshTissue Plasminogen Activator --therapeutic useen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleThrombolysis utilisation in acute myocardial infarction in Bahrain.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Heart Journal